March 31, 2026

FDA Monthly Preview: Key April Decisions to Watch

Several high-stakes FDA decisions across multiple specialties are expected this month.

Conexiant

March 30, 2026

Extended Viral PCR: Does It Help?

Researchers evaluate whether extended viral PCR testing is associated with antibiotic use and length of stay in adult inpatients.

Conexiant

March 27, 2026

FDA Approves Gene Therapy for Severe Pediatric LAD-I

Approval expands treatment option for a rare pediatric immunodeficiency

Conexiant

March 27, 2026

Meningococcal Abscess Detected by MRI

MRI identifies rare intracranial complication following normal computed tomography

Conexiant

March 27, 2026

UTICalc 3.0 Shows Promise for UTI Risk

Online risk tool may help guide urine testing decisions

Conexiant

March 23, 2026

Lyme Vaccine Advances in Late Trial

Large global study evaluates novel prevention strategy.

Conexiant

March 18, 2026

HPV Vaccine Delays Persist in Teens

Missed opportunities for HPV vaccination before sexual debut remain common, with practice variation and timing influencing uptake

Conexiant

March 17, 2026

Flu Vaccine Cut Hospitalizations Despite Drifted H3N2 Strain

Interim CDC estimates found the 2025–2026 vaccine reduced outpatient influenza visits by up to 41% and hospitalizations by up to 41%.

Conexiant

March 13, 2026

RSV Vaccine Eligibility Expands

Trial data show noninferior immune response in high-risk adults aged 18 to 49 years.

Conexiant

March 13, 2026

Clinicians Warn of Fatal Measles Brain Disease

Doctors caution that measles infection can lead to SSPE, a rare fatal neurologic disease that may appear years later.

KFF Health News